These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 7474103)

  • 1. High-level expression of adeno-associated virus (AAV) Rep78 or Rep68 protein is sufficient for infectious-particle formation by a rep-negative AAV mutant.
    Hölscher C; Kleinschmidt JA; Bürkle A
    J Virol; 1995 Nov; 69(11):6880-5. PubMed ID: 7474103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell lines inducibly expressing the adeno-associated virus (AAV) rep gene: requirements for productive replication of rep-negative AAV mutants.
    Hölscher C; Hörer M; Kleinschmidt JA; Zentgraf H; Bürkle A; Heilbronn R
    J Virol; 1994 Nov; 68(11):7169-77. PubMed ID: 7933099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 mRNA levels.
    Kyöstiö SR; Owens RA; Weitzman MD; Antoni BA; Chejanovsky N; Carter BJ
    J Virol; 1994 May; 68(5):2947-57. PubMed ID: 8151765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus Rep protein inhibits human immunodeficiency virus type 1 production in human cells.
    Antoni BA; Rabson AB; Miller IL; Trempe JP; Chejanovsky N; Carter BJ
    J Virol; 1991 Jan; 65(1):396-404. PubMed ID: 1845899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats, and Rep proteins.
    Weger S; Wistuba A; Grimm D; Kleinschmidt JA
    J Virol; 1997 Nov; 71(11):8437-47. PubMed ID: 9343200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated virus rep protein synthesis during productive infection.
    Redemann BE; Mendelson E; Carter BJ
    J Virol; 1989 Feb; 63(2):873-82. PubMed ID: 2536109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization.
    Im DS; Muzyczka N
    J Virol; 1992 Feb; 66(2):1119-28. PubMed ID: 1309894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters.
    Hörer M; Weger S; Butz K; Hoppe-Seyler F; Geisen C; Kleinschmidt JA
    J Virol; 1995 Sep; 69(9):5485-96. PubMed ID: 7636994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a DNA-binding domain in the amino terminus of adeno-associated virus Rep proteins.
    Owens RA; Weitzman MD; Kyöstiö SR; Carter BJ
    J Virol; 1993 Feb; 67(2):997-1005. PubMed ID: 8380475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular proteins required for adeno-associated virus DNA replication in the absence of adenovirus coinfection.
    Ni TH; McDonald WF; Zolotukhin I; Melendy T; Waga S; Stillman B; Muzyczka N
    J Virol; 1998 Apr; 72(4):2777-87. PubMed ID: 9525597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adeno-associated virus type 2 regulatory proteins rep78 and rep68 interact with the transcriptional coactivator PC4.
    Weger S; Wendland M; Kleinschmidt JA; Heilbronn R
    J Virol; 1999 Jan; 73(1):260-9. PubMed ID: 9847329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of adeno-associated virus Rep protein and human chromosome 19 in site-specific recombination.
    Young SM; McCarty DM; Degtyareva N; Samulski RJ
    J Virol; 2000 May; 74(9):3953-66. PubMed ID: 10756007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Functionally Relevant Adeno-Associated Virus Rep68 Oligomeric Interface.
    Bardelli M; Zárate-Pérez F; Agúndez L; Linden RM; Escalante CR; Henckaerts E
    J Virol; 2016 Aug; 90(15):6612-6624. PubMed ID: 27170758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence elements of the adeno-associated virus rep gene required for suppression of herpes-simplex-virus-induced DNA amplification.
    Kleinschmidt JA; Möhler M; Weindler FW; Heilbronn R
    Virology; 1995 Jan; 206(1):254-62. PubMed ID: 7831779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein.
    Kyöstiö SR; Wonderling RS; Owens RA
    J Virol; 1995 Nov; 69(11):6787-96. PubMed ID: 7474090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charge-to-alanine mutagenesis of the adeno-associated virus type 2 Rep78/68 proteins yields temperature-sensitive and magnesium-dependent variants.
    Gavin DK; Young SM; Xiao W; Temple B; Abernathy CR; Pereira DJ; Muzyczka N; Samulski RJ
    J Virol; 1999 Nov; 73(11):9433-45. PubMed ID: 10516052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated virus type 2 protein interactions: formation of pre-encapsidation complexes.
    Dubielzig R; King JA; Weger S; Kern A; Kleinschmidt JA
    J Virol; 1999 Nov; 73(11):8989-98. PubMed ID: 10516005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro replication of adeno-associated virus DNA.
    Ni TH; Zhou X; McCarty DM; Zolotukhin I; Muzyczka N
    J Virol; 1994 Feb; 68(2):1128-38. PubMed ID: 8289342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-associated virus rep proteins produced in insect and mammalian expression systems: wild-type and dominant-negative mutant proteins bind to the viral replication origin.
    Owens RA; Trempe JP; Chejanovsky N; Carter BJ
    Virology; 1991 Sep; 184(1):14-22. PubMed ID: 1651588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue and autonomous replication of adeno-associated virus type 2 genomes containing Rep-binding site mutations in the viral p5 promoter.
    Wang XS; Srivastava A
    J Virol; 1998 Jun; 72(6):4811-8. PubMed ID: 9573246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.